Your browser doesn't support javascript.
loading
Fixed dosing of kukoamine B in sepsis patients: Results from population pharmacokinetic modelling and simulation.
Wang, Huanhuan; Wang, Teng; Hu, Xiaoyun; Deng, Chenhui; Jiang, Ji; Qin, Hanyu; Dong, Kai; Chen, Shuai; Jin, Chunyan; Zhao, Qian; Du, Bin; Hu, Pei.
Afiliação
  • Wang H; Clinical Pharmacology Research Center, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Wang T; Clinical Pharmacology Department, Beijing Linking Truth Technology Co., Ltd, Beiing, China.
  • Hu X; Clinical Pharmacology Research Center, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Deng C; Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Jiang J; Medical ICU, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Qin H; Clinical Pharmacology Department, Beijing Linking Truth Technology Co., Ltd, Beiing, China.
  • Dong K; Clinical Pharmacology Research Center, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Chen S; Medical ICU, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Jin C; Clinical Research Center for Innovative Drugs, Tianjin Chase Sun Pharmaceutical Co., Ltd, Tianjin, China.
  • Zhao Q; Clinical Research Center for Innovative Drugs, Tianjin Chase Sun Pharmaceutical Co., Ltd, Tianjin, China.
  • Du B; Clinical Research Center for Innovative Drugs, Tianjin Chase Sun Pharmaceutical Co., Ltd, Tianjin, China.
  • Hu P; Clinical Pharmacology Research Center, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Br J Clin Pharmacol ; 88(9): 4111-4120, 2022 09.
Article em En | MEDLINE | ID: mdl-35373389
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sepse / Modelos Biológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sepse / Modelos Biológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article